Europeiska unionen -
estniska -
EMA (European Medicines Agency)
apoquel
zoetis belgium sa - oklatsitiniibmaleaat - dermatiidi ained, välja arvatud kortikosteroidid - koerad - - treatment of pruritus associated with allergic dermatitis in dogs. - treatment of clinical manifestations of atopic dermatitis in dogs.
Europeiska unionen -
estniska -
EMA (European Medicines Agency)
vargatef
boehringer ingelheim international gmbh - nintedanib - kartsinoom, mitteväikerakk-kopsu - antineoplastilised ained - vargatefil on näidustatud koos dotsetakseeliga lokaalselt levinud, metastaatilise või lokaalselt retsidiveerunud mitteväikerakk-kopsuvähiga (nsclc) täiskasvanud patsientide raviks, kasvaja lpatsientidest pärast esimese rea keemiaravi.
Europeiska unionen -
estniska -
EMA (European Medicines Agency)
zerbaxa
merck sharp & dohme b.v. - ceftolozane sulfate, tazobactam naatrium - bakteriaalsed infektsioonid - antibacterials süsteemseks kasutamiseks, - zerbaxa is indicated for the treatment of the following infections in adults:complicated intra abdominal infections;acute pyelonephritis;complicated urinary tract infections;hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap). tuleks arvesse võtta ametlikke juhiseid sobiva kasutada antibakteriaalseid aineid.
Europeiska unionen -
estniska -
EMA (European Medicines Agency)
carmustine medac (previously carmustine obvius)
medac gesellschaft für klinische spezialpräparate mbh - carmustine - hodgkin disease; lymphoma, non-hodgkin - antineoplastilised ained - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).
Estland -
estniska -
Ravimiamet
oxsynia toimeainet prolongeeritult vabastav tablett
mundipharma ges.m.b.h. - oksükodoon+naloksoon - toimeainet prolongeeritult vabastav tablett - 5mg+2,5mg 98tk; 5mg+2,5mg 28tk; 5mg+2,5mg 14tk; 5mg+2,5mg 100tk; 5mg+2,5mg 30tk; 5mg+2,5mg 50tk; 5mg+2,5mg 60tk
Estland -
estniska -
Ravimiamet
oxsynia toimeainet prolongeeritult vabastav tablett
mundipharma ges.m.b.h. - oksükodoon+naloksoon - toimeainet prolongeeritult vabastav tablett - 20mg+10mg 10tk; 20mg+10mg 50tk; 20mg+10mg 60tk; 20mg+10mg 100tk; 20mg+10mg 56tk
Estland -
estniska -
Ravimiamet
oxsynia toimeainet prolongeeritult vabastav tablett
mundipharma ges.m.b.h. - oksükodoon+naloksoon - toimeainet prolongeeritult vabastav tablett - 15mg+7,5mg 50tk; 15mg+7,5mg 56tk; 15mg+7,5mg 14tk; 15mg+7,5mg 28tk; 15mg+7,5mg 98tk; 15mg+7,5mg 100tk
Estland -
estniska -
Ravimiamet
geroxynal toimeainet prolongeeritult vabastav tablett
g.l. pharma gmbh - oksükodoon+naloksoon - toimeainet prolongeeritult vabastav tablett - 20mg+10mg 50tk; 20mg+10mg 98tk; 20mg+10mg 10tk; 20mg+10mg 56tk; 20mg+10mg 14tk; 20mg+10mg 100tk
Estland -
estniska -
Ravimiamet
geroxynal toimeainet prolongeeritult vabastav tablett
g.l. pharma gmbh - oksükodoon+naloksoon - toimeainet prolongeeritult vabastav tablett - 30mg+15mg 7tk; 30mg+15mg 20tk; 30mg+15mg 98tk; 30mg+15mg 28tk; 30mg+15mg 10tk; 30mg+15mg 60tk; 30mg+15mg 100tk; 30mg+15mg 14tk; 30mg+15mg 50tk; 30mg+15mg 56tk; 30mg+15mg 30tk
Estland -
estniska -
Ravimiamet
noldoxen toimeainet prolongeeritult vabastav tablett
krka d.d. novo mesto - oksükodoon+naloksoon - toimeainet prolongeeritult vabastav tablett - 40mg+20mg 100tk; 40mg+20mg 112tk; 40mg+20mg 30tk; 40mg+20mg 90tk; 40mg+20mg 28tk; 40mg+20mg 98tk; 40mg+20mg 20tk; 40mg+20mg 10tk